Skip to main content
SpringerLink
Log in
Book cover

Cardiovascular MR Manual pp 279–332Cite as

Cardiomyopathies

  • Chapter
  • First Online:

Abstract

In 1995, the World Health Organization (WHO) defined five classes of cardiomyopathies: Dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), restrictive cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy (ARVC), and unclassified cardiomyopathies. According to the more recent scientific statement on “contemporary definitions and classification of the cardiomyopathies” published in 2006 by the American Heart Association (AHA)1, cardiomyopathies are “a heterogeneous group of diseases of the myocardium associated with mechanical and/or electrical dysfunction that usually (but not invariably) exhibit inappropriate ventricular hypertrophy or dilatation and are due to a variety of causes that frequently are genetic. Cardiomyopathies either are confined to the heart or are part of generalized systemic disorders, often leading to cardiovascular death or progressive heart failure–related disability.” This new definition acknowledges the wide range of myocardial diseases, some of which are primary (predominantly involving the myocardium), others secondary (due to a systemic disease affecting other organs).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   44.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Maron BJ et al. Contemporary definitions and classification of the cardiomyopathies: An American Heart Association Scientific Statement From the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113(14):1807–1816.

    Article  PubMed  Google Scholar 

  2. Assomull RG et al. Cardiovascular Magnetic Resonance, Fibrosis, and Prognosis in Dilated Cardiomyopathy. J Am Coll Cardiol. 2006;48(10):1977–1985.

    Article  PubMed  Google Scholar 

  3. Moon JC et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2004;43(12):2260–2264.

    Article  PubMed  Google Scholar 

  4. McKenna WJ et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J. 1994;71(3):215–218.

    Article  PubMed  CAS  Google Scholar 

  5. Tandri H et al. MRI of arrhythmogenic right ventricular cardiomyopathy/dysplasia. J Cardiovasc Magn Reson. 2004;6(2):557–563.

    Article  PubMed  Google Scholar 

  6. Petersen SE et al. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol. 2005;46(1):101–105.

    Article  PubMed  Google Scholar 

  7. Mahrholdt H et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation. 2004;109(10):1250–1258.

    Article  PubMed  Google Scholar 

  8. Smedema J-P et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol. 2005;45(10):1683–1690.

    Article  PubMed  Google Scholar 

  9. Petersen SE, Kardos A, Neubauer S. Subendocardial and papillary muscle involvement in a patient with Churg-Strauss syndrome, detected by contrast enhanced cardiovascular magnetic resonance. Heart. 2005;91(1):e9.

    Article  PubMed  CAS  Google Scholar 

  10. Maceira AM et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2005;111(2):186–193.

    Article  PubMed  Google Scholar 

  11. Anderson LJ et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001;22(23):2171–2179.

    Article  PubMed  CAS  Google Scholar 

  12. Wittstein IS et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med. 2005;352(6):539–548.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Multidisciplinary Cardiovascular Research Centre (MCRC), Department of Cardiology, University of Leeds, G-Floor, Jubilee Wing, Leeds General Infirmary, Great George Street, Leeds, LS1 3EX, United Kingdom

    Sven Plein & John P. Greenwood

  2. Department of Medical Physics and Engineering, Leeds Teaching Hospitals NHS Trust, Leeds General Infirmary, Leeds, LS1 3EX, UK

    John P. Ridgway

Authors
  1. Sven Plein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John P. Greenwood
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. John P. Ridgway
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag London Limited

About this chapter

Cite this chapter

Plein, S., Greenwood, J.P., Ridgway, J.P. (2010). Cardiomyopathies. In: Cardiovascular MR Manual. Springer, London. https://doi.org/10.1007/978-1-84996-362-6_23

Download citation

  • DOI: https://doi.org/10.1007/978-1-84996-362-6_23

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84996-361-9

  • Online ISBN: 978-1-84996-362-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation